How Much Will I Get From the Zantac (Ranitidine) Cancer Settlement?

Based on the TBD (Est. $10B+) total fund and estimated claimant participation, the per-person payout for the Zantac (Ranitidine) Cancer Settlement is estimated at $50,000 – $300,000,000. However, actual payouts depend on the total number of valid claims filed and final court approval.

Individuals who regularly took Zantac (ranitidine) and were later diagnosed with cancer, particularly bladder, stomach, liver, esophageal, or pancreatic cancer.

Yes — this settlement requires documentation. You'll need proof of purchase, account statements, or other evidence showing your involvement with Sanofi, GSK, Boehringer Ingelheim, Pfizer. Providing documentation typically results in a higher payout.

The deadline to file a claim for the Zantac (Ranitidine) Cancer Settlement is December 31, 2026. That is 278 days from today. Make sure to file before this date to receive your share of the settlement.

Class action settlement payouts are calculated by dividing the total settlement fund by the number of valid claims submitted. Our estimates are based on historical participation rates for similar settlements. Actual amounts are determined by the settlement administrator after the filing deadline.

After the filing deadline passes, the settlement administrator reviews all claims, resolves disputes, and receives final court approval. This process typically takes 3–18 months. Once approved, payments are distributed via check, PayPal, Venmo, or gift cards depending on the settlement terms.